MyFinsight
Home
Blog
About
Contact
Download
Download image
Issuance of common stock
under inducement...
$6,473K
Issuance of common
warrants under february...
$4,531K
Issuance of common stock
under open market...
$1,305K
Issuance of common stock
under february 2025...
$996K
Proceeds from sale of
property and equipment
$110K
Pre-funded warrants
exercise
$2K
Net cash provided by
financing activities
$13,189K
Net cash provided by
investing activities
$108K
Canceled cashflow
$118K
Canceled cashflow
$2K
Increase (decrease) in
cash and cash...
-$13,093K
Canceled cashflow
$13,297K
Ipr&d impairment
$11,842K
Depreciation
$2,922K
Other current assets
-$2,243K
Stock-based compensation
$2,091K
Other long-lived
asset impairment
$1,653K
Trade account
payables
$1,238K
Finance expense
(income), net
-$256K
Loss from sale and
disposal of fixed assets,...
-$205K
February 2025 spa
issuance costs
$118K
Purchase of property and
equipment
$2K
Net cash used in
operating activities
-$26,390K
Canceled cashflow
$22,450K
Net loss
-$36,199K
Income from change in
fair value of...
$6,111K
Other account
payables
-$3,430K
Gain from early lease
termination
$2,949K
Revaluation of contingent
consideration
-$77K
Net change in
operating leases
-$74K
Back
Back
Cash Flow
source: myfinsight.com
BiomX Inc. (PHGE)
BiomX Inc. (PHGE)